Nobel Prize 2026: Optogenetics Pioneers Honored for Lighting Up the Brain
The 2026 Nobel Prize in Physiology or Medicine recognizes Karl Deisseroth, Peter Hegemann and Georg Nagel for optogenetics, the technique that lets scientists control specific neurons with light...
A New Mechanism for Parkinson’s Disease: FDA Approves Tavapadon, the First D1/D5 Dopamine Agonist
Tavapadon (Juvmo) is the first selective D1/D5 dopamine receptor agonist approved for Parkinson's disease, offering a once-daily option with or without levodopa...
Treating the Cause, Not Just the Symptoms: First Orexin Agonist Approved for Narcolepsy Type 1
Oveporexton (Orzeyful) is the first approved drug that directly restores orexin signaling, the biological deficit behind narcolepsy type 1...
Alzheimer’s Treatment at Home: FDA Approves Subcutaneous Lecanemab From the First Dose
Leqembi Iqlik becomes the first anti-amyloid therapy that can be started at home with a weekly autoinjector, without intravenous infusions...
Brain-Computer Interfaces Leave the Lab: Man With ALS Communicates Independently at Home for Two Years
A Nature Medicine study shows an implanted brain-computer interface used almost daily at home for nearly two years, with nearly 2 million words communicated...
First Treatment for Alexander Disease: Antisense Therapy Targets the Root Cause
Zilganersen (Zanvastro) is the first FDA-approved therapy for Alexander disease, reducing production of the toxic GFAP protein that damages astrocytes...
One Brain, Two Origins: Stanford Study Finds the Brain Develops From Two Separate Cell Populations
Research in Nature Neuroscience shows the forebrain and midbrain arise from different progenitor cells than the hindbrain, opening new ways to model ALS and SMA...
Huntington’s Disease Gene Therapy Reaches FDA Review for the First Time
The FDA accepted uniQure's application for AMT-130, a one-time gene therapy that silences the huntingtin gene, under priority review with a decision expected by May 2027...
Brain-Activated CAR-T Cells Clear a Deadly Childhood Brain Tumor in Preclinical Models
UCSF's B-SYNC CAR-T cells switch on only inside the brain and eliminated diffuse midline glioma in every mouse tested, with a clinical trial planned for 2027...
Breakthrough in Epilepsy Treatment: New Medications Revolutionize Care for Difficult-to-Treat Cases
New medications are transforming epilepsy care, offering effective options for difficult-to-treat cases and improving quality of life for patients worldwide...


